Abstract
4
exclusively depends on glutamine because the amination of the synthesis reaction requires 69 glutamine 23, 24 . The biosynthesis of asparagine using glutamine is catalyzed by the enzyme 70 asparagine synthetase (ASNS) 25, 26 .
72
A new and growing body of work suggests asparagine is more than a polypeptide subunit but is 73 also essential in coordinating overall protein synthesis, cellular responses to amino acid 74 homeostasis, and metabolic availability during biological processes and disease development.
75
For example, asparagine acts as a metabolic regulator of TCA cycle intermediates and the 76 cellular supply of nitrogen (which supports the synthesis of non-essential amino acids); and for
77
cancer cells, asparagine bioavailability is essential for survival, proliferation and tumor 78 development 23, 24, 27, 28 . Asparagine is also important for supporting kaposi's sarcoma-associated
79
herpes virus (KSHV) transformed cancer cell proliferation during glutamine depletion 29 .
80
However, the role of asparagine and its availability in virus replication has not been explored.
82
In the current study, we show that asparagine is a limiting metabolite for VACV replication 
92

Results
93
Asparagine fully rescues VACV replication from glutamine depletion
5
To test why VACV prefers glutamine to glucose for efficient replication, we examined whether α-
95
KG and glutamate-the products of glutaminolysis that feed the TCA cycle (Fig. 1A) 
98
in agreement with an earlier study (Fig. 1B) 14 . This indicates that while anaplerosis of the TCA
99
cycle is important, this function of glutamine is not responsible for its superiority to glucose in 100 promoting VACV replication.
102
Notably, VACV replication was fully rescued from glutamine depletion when asparagine was 103 added to the medium (Fig. 1B) . In contrast, when the medium contained glutamine, adding 104 asparagine did not boost viral titers, suggesting growth could be equally rescued by either 105 glutamine or asparagine.
107
Normal VACV replication kinetics in glutamine-free medium was also consistently rescued by 108 asparagine (over a 72-h replication period, when the initial VACV multiplicity of infection (MOI) 109 was 0.001; Fig. 1C ). Accordingly, in VACV-infected cells grown in the absence of glutamine,
110
asparagine rescued GFP expression from the VACV late promoter (Fig. S1 ). In medium
111
containing glucose only, the 72-h proliferation rate of HFFs differed little from cells grown in 112 glucose plus glutamine, or glucose plus asparagine (Fig. 1D) , suggesting the difference in
113
VACV titers is not due to cytotoxicity or altered HFF proliferation. Other non-essential amino 114 acids that can be synthesized from glutamine, but were not present in the cell culture medium
115
(e.g., proline, alanine, and serine), did not rescue VACV replication from glutamine-deficiency
116
( Fig. 1E) Fig. 2A ), while addition of asparagine did not ( Fig. 2A) 
136
Our interpretation is also supported by the fact that, in VACV-infected cells, the TCA cycle is not 137 directly fed by asparagine converting to aspartate: adding aspartate to glutamine-deficient 138 medium rescued only low levels of VACV replication (Fig. 2D) ; adding asparagine did not 139 elevate aspartate concentration (Fig. 3A) , which is consistent with the fact that in mammalian 140 cells asparaginase does not actively convert asparagine to aspartate 28 . Notably, glutamine,
141
itself, could support VACV replication, even in the absence of glucose, while asparagine-142 mediated rescue of VACV replication, from glutamine depleted conditions, required glucose in 143 the medium (Fig. 2E) .
145 7
For VACV-infected HFFs cultured in glutamine-deficient medium, adding asparagine did not 146 increase the glutamine and glutamate concentration either (Fig. 3A) . Moreover, an inhibitor of
147
de novo glutamine synthesis, L-MSO, only minimally reduced VACV replication (1.4-fold) when 148 glutamine-deficient medium was supplemented with asparagine ( Fig. 2F) 
157
had a lower or similar concentration (Fig. 3A) . Among the five amino acids, asparagine is the 158 only amino acid that exclusively requires glutamine for its biosynthesis is also the only amino
159
acid that fully rescues VACV replication from glutamine depletion. Remarkably, adding
160
asparagine significantly decreased accumulation of most amino acids in glutamine-depleted 161 conditions (Fig. 3A) . Moreover, asparagine concentration was significantly lower than other 162 amino acids except glutamine in glucose only condition, while its level was significantly higher
163
than or similar to most other amino acids when glutamine is present (Fig. 3B) .
165
These results prompted us to hypothesize that asparagine availability is a critical limiting factor (Fig. S2) . In uninfected HFFs, these pathways were also only slightly 184 affected or not affected (Fig. S2) . This observation is consistent to the results that the most of 185 amino acid levels increased in medium containing glucose only (Fig. 3A) . 
206
Our metabolic profiling of cultures grown with glucose or asparagine supplementation showed 207 that they had similar nucleoside concentrations (Fig. S3A) . Accordingly, adding nucleosides to 208 glutamine-depleted medium did not rescue VACV replication (Fig. S3B) . These results support 209 the conclusion that asparagine has little effect on VACV RNA production but significantly
210
elevates post-replicative mRNA translation.
212
ASNS knockdown impairs VACV replication
213
Standard cell culture medium lacks asparagine, and cells synthesize it de novo by ASNS, using 214 glutamine as the amino group donor (Fig. 5A ). To test whether asparagine biosynthesis affects
215
VACV replication, ASNS protein expression was blocked with two specific siRNAs (Fig. 5B) .
216
ASNS knockdown significantly impaired VACV replication (Fig. 5C, 5D ), but did not suppress 217 cell proliferation (Fig. S4) . In ASNS-siRNA-treated cells, VACV protein synthesis was down-218 regulated (Fig. 5E ). This agrees with the result that siRNA-mediated interference of ASNS also 219 decreased nascent protein synthesis in VACV-infected cells but not uninfected cells (Fig. 5F ).
220
Since these experiments were performed in the presence of glutamine, the results indicate a 221 10 
232
asparagine and glutamine, asparaginase had no effect (Fig. 6B) . Importantly, asparaginase 233 treatment did not decrease cell viability (Fig. 6C) .
235
To test whether chemical interference of ASNS impedes VACV replication, the ASNS 236 competitive inhibitor, albizziine 40 , was added to culture medium. In medium with glutamine, 237 albizziine reduced VACV replication by 41-fold but had no obvious effect on VACV replication in 238 cells grown with glucose only (Fig. 6E) . In cells grown with asparagine plus glucose, albizziine 239 reduced VACV titers by only two-fold (Fig. 6E) . Furthermore, albizziine treatment decreased
240
Gaussia luciferase activity in vLGluc-infected HFFs grown with medium containing glutamine 241 and glucose, but not glucose only (Fig. S6) . Albizziine had no effect on cell viability (Fig. 6F) . 
250
containing medium, glutamine not only feeds the TCA cycle, it also is a substrate for asparagine 251 synthesis, which supports the synthetic pathways supporting VACV replication (Fig. 7A ).
252
Because de novo synthesis of asparagine uses glutamine as the amino-group donor ,
253
asparagine cannot be synthesized in the absence of glutamine-this renders asparagine a 254 limiting metabolite that must be exogenously supplied (Fig. 7B) (Fig. 3A) , and that aspartate in the absence of glutamine only weakly rescued
278
VACV replication (Fig. 2D) . In addition, asparagine needed glucose to rescue VACV replication 279 from glutamine depletion (Fig. 2E) . This is further supported by global metabolic-profiling data
280
showing asparagine addition does not enhance TCA cycle activities in glutamine-depleted 281 conditions ( Fig. 2A) . All of these facts support the idea that asparagine is not a carbon source 282 during rescue of VACV replication from glutamine depletion.
283
Asparagine availability is critical for supporting VACV replication. Although glutamine can
284
contribute to the biosynthesis of several non-essential amino acids via glutamate, asparagine 285 biosynthesis exclusively requires glutamine 23, 24 . We showed that rescue of VACV replication 286 from glutamine depletion is specific to asparagine (Fig. 1D) 
337
Bovine Serum (FBS, Peak Serum), 2 mM Glutamine (VWR), and 100 U/ml of Penicillin, 100
µg/ml Streptomycin (VWR). BS-C-1 cells (ATCC CCL-26) were grown in EMEM (Fisher
339
Scientific) supplemented with 10% FBS, 2 mM Glutamine, and 100 U/ml of Penicillin, 100 µg/ml
340
Streptomycin. All cells were incubated at 37°C in an incubator with 5% CO 2 . VACV Western
341
Reserve (WR) strain (ATCC VR-1354) was used in this study. Amplification, purification,
342
infection, and titration of VACV were carried out using methods described elsewhere 55 . 
381
Proprietary analytical procedures were carried out to ensure highest quality data after 382 minimizing the system artifacts, misassignments, and background noise among the samples.
383
The raw reads were first normalized in terms of raw area counts and then each biochemical was 384 rescaled to set the median equal to one. Then, missing values were imputed with the minimum.
385
Values for each sample were normalized by Bradford protein concentration in each sample.
386
Each biochemical was then rescaled to set the median equal to one and again missing values
387
were imputed with the minimum. Three-way analysis of variation (ANOVA) with contrast tests 388 was performed to calculate the fold change of metabolites.
390
Cell viability assays
391
For the trypan-blue exclusion assay, cell viability was measured as described elsewhere 57 .
392
Briefly, after treatment, cells of each well (12-well plate) were treated with 300 µl of trypsin and 
397
allowing to grow overnight in a 37°C incubator, followed by necessary treatments and the 398 absorbance measurement at 570 nm using a microplate reader. 
Gaussia luciferase assay
416
and developed with chemiluminescent substrate (National Diagnostics). The whole procedure
417
was carried out at room temperature. Antibodies were stripped from the membrane by Restore 418 buffer (Thermo Fisher Scientific) for Western blotting analysis using another antibody.
420
To label the newly synthesized proteins, 10 µg/mL of Puromycin (Sigma Aldrich) was added to 421 the cells 10 min prior to sample collection. The cells were then harvested for immunoblotting 422 using anti-puromycin antibody.
424
Real-Time PCR (RT-PCR)
18
Total RNA was extracted using TRIzol reagent (Ambion) followed by purification using
426
Invitrogen PureLink RNA Mini Kit (Thermo Fisher Scientific). The RNA was used to synthesize 
644
Aspartate is not as efficient as asparagine in supporting VACV replication. VACV titers in HFFs 645 infected with VACV, at an MOI of 2 for 24 h, in indicated medium were measured by a plaque 
